Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

MAP3K13 Antikörper (AA 506-835) (HRP)

MAP3K13 Reaktivität: Human ELISA Wirt: Kaninchen Polyclonal HRP
Produktnummer ABIN7160028
  • Target Alle MAP3K13 Antikörper anzeigen
    MAP3K13 (Mitogen-Activated Protein Kinase Kinase Kinase 13 (MAP3K13))
    Bindungsspezifität
    • 15
    • 13
    • 7
    • 5
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 506-835
    Reaktivität
    • 54
    • 30
    • 14
    • 1
    • 1
    • 1
    • 1
    Human
    Wirt
    • 51
    • 3
    Kaninchen
    Klonalität
    • 53
    • 1
    Polyklonal
    Konjugat
    • 20
    • 5
    • 5
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser MAP3K13 Antikörper ist konjugiert mit HRP
    Applikation
    • 43
    • 26
    • 18
    • 13
    • 13
    • 6
    • 3
    • 3
    • 3
    • 2
    ELISA
    Kreuzreaktivität
    Human
    Aufreinigung
    >95%, Protein G purified
    Immunogen
    Recombinant Human Mitogen-activated protein kinase kinase kinase 13 protein (506-835AA)
    Isotyp
    IgG
    Top Product
    Discover our top product MAP3K13 Primärantikörper
  • Applikationshinweise
    Optimal working dilution should be determined by the investigator.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Buffer
    Preservative: 0.03 % Proclin 300
    Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4
    Konservierungsmittel
    ProClin
    Vorsichtsmaßnahmen
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    -20 °C,-80 °C
    Informationen zur Lagerung
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Target
    MAP3K13 (Mitogen-Activated Protein Kinase Kinase Kinase 13 (MAP3K13))
    Andere Bezeichnung
    MAP3K13 (MAP3K13 Produkte)
    Synonyme
    LZK antikoerper, MEKK13 antikoerper, MLK antikoerper, C130026N12Rik antikoerper, lzk antikoerper, map3k13 antikoerper, map3k13a antikoerper, mekk13 antikoerper, map3k13-a antikoerper, map3k13-b antikoerper, map3k13b antikoerper, mitogen-activated protein kinase kinase kinase 13 antikoerper, mitogen-activated protein kinase kinase kinase 13 L homeolog antikoerper, mitogen-activated protein kinase kinase kinase 13 S homeolog antikoerper, MAP3K13 antikoerper, Map3k13 antikoerper, map3k13.L antikoerper, map3k13 antikoerper, map3k13.S antikoerper
    Hintergrund

    Background: Activates the JUN N-terminal pathway through activation of the MAP kinase kinase MAP2K7. Acts synergistically with PRDX3 to regulate the activation of NF-kappa-B in the cytosol. This activation is kinase-dependent and involves activating the IKK complex, the IKBKB-containing complex that phosphorylates inhibitors of NF-kappa-B.

    Aliases: EC 2.7.11.25 antibody, Leucine zipper bearing kinase antibody, Leucine zipper-bearing kinase antibody, LZK antibody, M3K13_HUMAN antibody, MAP3K13 antibody, MEKK13 antibody, MGC133196 antibody, Mitogen activated protein kinase kinase kinase 13 antibody, Mitogen-activated protein kinase kinase kinase 13 antibody, Mixed lineage kinase antibody, MLK antibody, OTTHUMP00000210397 antibody

    UniProt
    O43283
    Pathways
    Signaling Events mediated by VEGFR1 and VEGFR2
Sie sind hier: